Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
Milestone enables Codexis engineers to model the manufacturing process for RNAi therapeutics
Company remains on track to initiate pre-commercial customer testing in 2024
Related news for (CDXS)
- Today’s Top Performers: MoBot’s Market Review 08/14/25 10:00 AM
- Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA
- Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting
- Codexis Announces Byron Dorgan to Retire from Board of Directors
- 24/7 Market News Snapshot 09 April, 2025 – Codexis, Inc. (NASDAQ:CDXS)